Usability and Usefulness of a Symptom Management Coaching System for Patients With Cancer Treated With Immune Checkpoint Inhibitors: Comparative Mixed Methods Study

Despite identified usability issues, participants responded positively to the Perceived Usefulness questionnaire regarding the evaluated tool. Further analysis of the usability problems indicates that it was essential to include participants who matched the target end users. Participants treated with immunotherapy, specifically with previous experience in immune-related adverse events, encountered critical problems with symptom reporting that would not have been identified if these participants were not included. For other tasks and functionalities, it seems likely that loosening the inclusion criteria would have resulted in sufficient feedback without critical missing usability issues.

Authors

Institutions

Publication Details

Journal
JMIR Formative Research
Published
2024-11-13
DOI
https://doi.org/10.2196/57659
Citations
3
Primary Topic
Cancer survivorship and care
Type
article
Field-Weighted Citation Impact
0.85

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Usability and Usefulness of a Symptom Management Coaching System for Patients With Cancer Treated With Immune Checkpoint Inhibitors: Comparative Mixed Methods Study

Henk Mallo, Vitali Hisko, Ronald Cornet, Savannah Glaser et al.
3 citations
JMIR Formative Research
Cancer survivorship and care
0.85
article

Usability and Usefulness of a Symptom Management Coaching System for Patients With Cancer Treated With Immune Checkpoint Inhibitors: Comparative Mixed Methods Study

Henk Mallo, Vitali Hisko, Ronald Cornet, Savannah Glaser, Sofie Wilgenhof, Itske Fraterman, Szymon Wilk, Manuel Ottaviano, Valentina Tibollo, Stephanie Medlock, Noah van Brummelen, Laura Maria Del Campo, Vadzim Khadakou
article en
3 citations

Abstract

Despite identified usability issues, participants responded positively to the Perceived Usefulness questionnaire regarding the evaluated tool. Further analysis of the usability problems indicates that it was essential to include participants who matched the target end users. Participants treated with immunotherapy, specifically with previous experience in immune-related adverse events, encountered critical problems with symptom reporting that would not have been identified if these participants were not included. For other tasks and functionalities, it seems likely that loosening the inclusion criteria would have resulted in sufficient feedback without critical missing usability issues.

JMIR Formative ResearchVol. 9
The Netherlands Cancer Institute (NL), Istituti Clinici Scientifici Maugeri (IT), Italian Association for Cancer Research (IT), GGD Amsterdam (NL), Public Health Service of Amsterdam (NL), Amsterdam University Medical Centers (NL), Poznań University of Technology (PL), Universidad Politécnica de Madrid (ES), University of Amsterdam (NL)
European Commission
Openalex Percentile: Top 22%
Cancer survivorship and care
0.85
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.